These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37417652)

  • 1. A model for predicting poor survival in patients with cirrhosis undergoing portosystemic shunt embolization.
    Choi WM; Yoo SY; Chang JI; Han S; Kim YS; Sinn DH; Choi SH; Gwon DI; Lim YS
    J Gastroenterol Hepatol; 2023 Sep; 38(9):1629-1636. PubMed ID: 37417652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of artificial intelligence for prognostic prediction with the albumin-bilirubin and platelet-albumin-bilirubin for cirrhotic patients with acute variceal bleeding undergoing early transjugular intrahepatic portosystemic shunt.
    Zhong BY; Tang HH; Wang WS; Shen J; Zhang S; Li WC; Yin Y; Yang J; Liu F; Ni CF; Zhao JB; Zhu XL
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e153-e160. PubMed ID: 33177378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative prediction of overt hepatic encephalopathy caused by transjugular intrahepatic portosystemic shunt.
    Yang Y; Liang X; Yang S; He X; Huang M; Shi W; Luo J; Duan C; Feng X; Fu S; Lu L
    Eur J Radiol; 2022 Sep; 154():110384. PubMed ID: 35667296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis.
    He C; Lv Y; Wang Z; Guo W; Tie J; Li K; Niu J; Zuo L; Yu T; Yuan X; Chen H; Wang Q; Liu H; Bai W; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Wang J; Yin Z; Fan D; Han G
    Dig Liver Dis; 2018 Dec; 50(12):1315-1323. PubMed ID: 29960900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.
    Jalan R; Elton RA; Redhead DN; Finlayson ND; Hayes PC
    J Hepatol; 1995 Aug; 23(2):123-8. PubMed ID: 7499782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
    Bettinger D; Sturm L; Pfaff L; Hahn F; Kloeckner R; Volkwein L; Praktiknjo M; Lv Y; Han G; Huber JP; Boettler T; Reincke M; Klinger C; Caca K; Heinzow H; Seifert LL; Weiss KH; Rupp C; Piecha F; Kluwe J; Zipprich A; Luxenburger H; Neumann-Haefelin C; Schmidt A; Jansen C; Meyer C; Uschner FE; Brol MJ; Trebicka J; Rössle M; Thimme R; Schultheiss M
    J Hepatol; 2021 Jun; 74(6):1362-1372. PubMed ID: 33508376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transjugular intrahepatic portosystemic shunt in decompensated cirrhotic patients in a tertiary hospital in southern Brazil.
    Titton CM; Torikachvili M; Rêgo HMC; Medronha EF; Ziemiecki Junior E; Ribas C; Ceratti CG; Mattos AA; Tovo CV
    Rev Assoc Med Bras (1992); 2023; 69(4):e20220944. PubMed ID: 37075438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question.
    Pitton MB; Zimmermann T; Mildenberger P; Weinmann A; Kloeckner R; Düber C; Mittler J; Hoppe-Lotichius M; Otto G
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e214-e222. PubMed ID: 33230020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of albumin-bilirubin score to predict hepatic encephalopathy in patients underwent transjugular intrahepatic portosystemic shunt.
    Lin X; Gao F; Wu X; Cai W; Chen X; Huang Z
    Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):862-871. PubMed ID: 32541240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
    Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
    Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for end-stage liver disease score and hemodynamic instability as a predictor of poor outcome in early transjugular intrahepatic portosystemic shunt treatment for acute variceal hemorrhage.
    Hermie L; Dhondt E; Vanlangenhove P; Hoste E; Geerts A; Defreyne L
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1441-1446. PubMed ID: 30048333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
    Tejedor-Tejada J; Fuentes-Valenzuela E; García-Pajares F; Nájera-Muñoz R; Almohalla-Álvarez C; Sánchez-Martín F; Calero-Aguilar H; Villacastín-Ruiz E; Pintado-Garrido R; Sánchez-Antolín G
    Gastroenterol Hepatol; 2021 Nov; 44(9):620-627. PubMed ID: 33249114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
    World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
    Brand M; Prodehl L; Ede CJ
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
    Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A
    United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular Intrahepatic Portosystemic Shunt Creation and Variceal Coil or Plug Embolization Ineffectively Attain Gastric Variceal Decompression or Occlusion: Results of a 26-Patient Retrospective Study.
    Lakhoo J; Bui JT; Lokken RP; Ray CE; Gaba RC
    J Vasc Interv Radiol; 2016 Jul; 27(7):1001-11. PubMed ID: 27106732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
    Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
    World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.
    Simonetti RG; Perricone G; Robbins HL; Battula NR; Weickert MO; Sutton R; Khan S
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD000553. PubMed ID: 33089892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update in the Treatment of the Complications of Cirrhosis.
    Abraldes JG; Caraceni P; Ghabril M; Garcia-Tsao G
    Clin Gastroenterol Hepatol; 2023 Jul; 21(8):2100-2109. PubMed ID: 36972759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Centre Retrospective Training Cohort Using Artificial Intelligence for Prognostic Prediction of Encephalopathy, Mortality, and Liver Dysfunction after Early TIPS Creation.
    Zhong BY; Wang WS; Shen J; Du H; Zhang S; Li WC; Yin Y; Yang J; Ni CF; Zhu XL
    Cardiovasc Intervent Radiol; 2021 Oct; 44(10):1597-1608. PubMed ID: 34240232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.